[1]David M, Petit D, Bertoglio J. Cell cycle regulation of Rho signaling pathways [J]. Cell Cycle, 2012, 11(16): 3003-3010

[2]Vigil D, Cherfils J, Rossman KL, et al. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? [J]. Nat Rev Cancer, 2010, 10(12): 842-857

[3]Mittnacht S, Paterson H, Olson MF, et al. Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein [J]. Curr Biol, 1997, 7(3): 219-221

[4]Pruitt K, Der CJ. Ras and Rho regulation of the cell cycle and oncogenesis [J]. Cancer Lett, 2001, 171(1): 1-10

[5]Coleman ML, Marshall CJ, Olson MF. RAS and RHO GTPases in G1-phase cell-cycle regulation [J]. Nat Rev Mol Cell Biol, 2004, 5(5): 355-366

[6]Downward J. Ras signalling and apoptosis [J]. Curr Opin Genet Dev, 1998, 8(1): 49-54

[7]Gille H，Downward J.Multiple ras effector pathways contribute to G(1) cell cycle progression [J]. J Biol Chem, 1999, 274(31): 22033-22040

[8]Diehl JA, Cheng M, Roussel MF, et al. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization [J]. Genes Dev, 1998, 12(22): 3499-3511

[9]Muise-Helmericks RC, Grimes HL, Bellacosa A, et al. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway [J]. J Biol Chem, 1998, 273(45): 29864-29872

[10]Delmas C, Manenti S, Boudjelal A, et al. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells [J]. J Biol Chem, 2001, 276(37): 34958-34965

[11]Rivard N, Boucher MJ, Asselin C, et al. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells [J]. Am J Physiol, 1999, 277(4 Pt 1): C652-664

[12]Takuwa N, Takuwa Y. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts [J]. Mol Cell Biol, 1997, 17(9): 5348-5358

[13]LaBaer J, Garrett MD, Stevenson LF,  et al. New functional activities for the p21 family of CDK inhibitors [J]. Genes Dev, 1997, 11(7): 847-862

[14]Cheng M, Olivier P, Diehl JA, et al. The p21 (Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts [J]. Embo J, 1999, 18(6): 1571-1583

[15]Alt JR, Gladden AB, Diehl J A. p21 (Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export [J]. J Biol Chem, 2002, 277(10): 8517-8523

[16]Woods D, Parry D, Cherwinski H, et al., Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 [J]. Mol Cell Biol, 1997, 17(9): 55985-55611

[17]Sewing A, Wiseman B, Lloyd AC, et al. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 [J]. Mol Cell Biol, 1997, 17(9): 5588-5597

[18]Madaule P， Axel R.A novel ras-related gene family [J]. Cell, 1985, 41(1): 31-40

[19]Vega FM，Ridley AJ.Rho GTPases in cancer cell biology [J]. FEBS Lett, 2008, 582(14): 2093-2101

[20]Gu Y, Jasti AC, Jansen M, et al. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival,migration and engraftment of hematopoietic progenitor cells[J].Blood,2005,105(4):1467-1475

[21]Gu Y, Zheng Y， Williams DA. RhoH GTPase: a key regulator of hematopoietic cell proliferation and apoptosis? [J]. Cell Cycle, 2005, 4(2): 201-202

[22]Rossman K L, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors [J]. Nat Rev Mol Cell Biol, 2005, 6(2): 167-180

[23]Heasman SJ， Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies [J]. Nat Rev Mol Cell Biol, 2008, 9(9): 690-701

[24]Sherr C，Roberts JM.CDK inhibitors: positive and negative regulators of G1-phase progression [J]. Genes Dev, 1999, 13(12): 1501-1512

[25]Villalonga P, Ridley AJ. Rho GTPases and cell cycle control[J].Growth Factors, 2006, 24(3):159-164

[26]Ewen ME, Sluss HK, Sherr CJ, et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins [J]. Cell, 1993, 73(3): 487-497

[27]Vlach J, Hennecke S, Amati,B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27 [J]. EMBO J, 1997, 16(17): 5334-5344

[28]Dynlacht BD, Flores O, Lees JA, et al. Differential regulation of E2F transactivation by cyclin/cdk2 complexes [J]. Genes Dev, 1994, 8(15): 1772-1786

[29]Pardee AB. G1 events and regulation of cell proliferation [J]. Science, 1989, 246(4930): 603-608

[30]Yamamoto M, Marui N, Sakai T, et al. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle [J]. Oncogene, 1993, 8(6): 1449-1455

[31]Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1 [J]. Science, 1995, 269(5228): 1270-1272

[32]Vogt A, Sun J, Qian Y, et al. The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner [J]. J Biol Chem, 1997, 272(43): 27224-27229

[33]Qiu RG, Chen J, Kirn D, et al. An essential role for Rac in Ras transformation [J]. Nature, 1995, 374 (6521): 457-459

[34]Qiu RG, Chen J, McCormick F, et al. A role for Rho in Ras transformation [J]. Proc Natl Acad Sci U S A, 1995, 92(25): 11781-11785

[35]Qiu RG, Abo A, McCormick F, et al. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation [J]. Mol Cell Biol, 1997, 17(6): 3449-3458

[36]Diehl JA. Cycling to cancer with cyclin D1 [J]. Cancer Biol Ther, 2002, 1(3): 226-231

[37]Croft DR, Olson M F.The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms [J]. Mol Cell Biol, 2006, 26(12): 4612-4627

[38]Welsh CF, Assoian RK. A growing role for Rho family GTPases as intermediaries in growth factor- and adhesion-dependent cell cycle progression [J]. Biochim Biophys Acta, 2000, 1471(1): M21-29

[39]Bourdoulous S, Orend G, MacKenna DA, et al. Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression [J]. J Cell Biol, 1998, 143(1): 267-276

[40]Welsh CF, Roovers K, Villanueva J, et al. Timing of cyclin D1 expression within G1 phase is controlled by Rho [J]. Nat Cell Biol, 2001, 3(11): 950-957

[41]Mettouchi A, Klein S, Guo W ,et al. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle [J]. Mol Cell, 2001, 8(1): 115-127

[42]Joyce D, Bouzahzah B, Fu M, et al.Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway [J]. J Biol Chem, 1999, 274(36): 25245-25249

[43]Gjoerup O, Lukas J, Bartek J, et al. Rac and Cdc42 are potent stimulators of E2F-dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation [J]. J Biol Chem, 1998, 273(30): 18812-18818

[44]Hu W, Bellone CJ, Baldassare J J. RhoA stimulates p27 (Kip) degradation through its regulation of cyclin E/CDK2 activity [J]. J Biol Chem, 1999, 274(6): 3396-3401

[45]Vidal A, Millard SS, Miller JP, et al. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status [J]. J Biol Chem, 2002, 277(19): 16433-16440

[46]Olson MF, Paterson H F, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 [J]. Nature, 1998, 394(6690): 295-299

[47]Guasch RM, Scambler P, Jones GE, et al. RhoE regulates actin cytoskeleton organization and cell migration [J]. Mol Cell Biol, 1998, 18(8): 4761-4771

[48]Talens-Visconti R, Peris B, Guerri C,  et al. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-I signalling [J]. J Neurochem, 2010, 112(4): 1074-1087

[49]Riento K, Guasch RM, Garg R, et al. RhoE binds to ROCK I and inhibits downstream signaling [J]. Mol Cell Biol, 2003, 23(12): 4219-4229

[50]Riento K, Ridley A J.Inhibition of ROCK by RhoE [J]. Methods Enzymol, 2006, 406: 533-541

[51]Villalonga P, Guasch RM, Riento K, et al. RhoE inhibits cell cycle progression and Ras-induced transformation [J]. Mol Cell Biol, 2004, 24(18): 7829-7840

[52]Riou P, Villalonga P, Ridley AJ.Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression [J]. Bioessays, 2010, 32(11): 986-992

[53]Chardin P. Function and regulation of Rnd proteins [J]. Nat Rev Mol Cell Biol, 2006, 7(1): 54-62

[54]Gündogdu MS, Liu H, Metzdorf D, et al. The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression[J].Mol Cancer,2010, 9: 225

[55]Fueller F, Kubatzky KF. The small GTPase RhoH is an atypical regulator of haematopoietic cells [J]. Cell Commun Signal, 2008, 6: 6

[56]Wilkins A, Carpenter CL. Regulation of RhoBTB2 by the Cul3 ubiquitin ligase complex[J]. Methods Enzymol, 2008, 439: 103-109

[57]Wilkins A, Ping Q, Carpenter C L. RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex [J]. Genes Dev, 2004, 18(8): 856-861

[58]Mao H, Zhang L, Yang Y, et al. RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells[J].Gene,2011, 486(1-2): 74-80

[59]Berthold J, Schenkova K, Rivero F.  Rho GTPases of the RhoBTB subfamily and tumorigenesis [J]. Acta Pharmacol Sin, 2008, 29(3): 285-295

[60]Siripurapu V, Meth J, Kobayashi N, et al. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways [J]. J Mol Biol, 2005, 346(1): 83-89

[61]Vincent S, Jeanteur P, Fort P. Growth-regulated expression of rhoG, a new member of the ras homolog gene family [J]. Mol Cell Biol, 1992, 12(7): 3138-3148

[62]Gauthier-Rouvière C, Vignal E, Mériane M, et al. RhoG GTPase controls a pathway that independently activates Rac1 and Cdc42Hs [J]. Mol Biol Cell, 1998, 9(6): 1379-1394

[63]Roux P, Gauthier-Rouvière C, Doucet-Brutin S, et al. The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells [J]. Curr Biol, 1997, 7 (9): 629-637

[64]Murphy GA, Solski PA, Jillian SA, et al. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth [J]. Oncogene, 1999, 18(26): 3831-3845

[65]Murphy GA, Jillian SA, Michaelson D, et al. Signaling mediated by the closely related mammalian Rho family GTPases TC10 and Cdc42 suggests distinct functional pathways [J]. Cell Growth Differ, 2001, 12(3): 157-167

[66]Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking [J]. Trends Cell Biol, 2006, 16(10): 522-529

[67]Gad A K, Aspenstrom P. Rif proteins take to the RhoD: Rho GTPases at the crossroads of actin dynamics and membrane trafficking [J]. Cell Signal, 2010, 22(2):183-189

[68]Tsubakimoto K, Matsumoto K, Abe H, et al. Small GTPase RhoD suppresses cell migration and cytokinesis [J]. Oncogene, 1999, 18(15): 2431-2440

[69]Kyrkou A, Soufi M, Bahtz R, et al. RhoD participates in the regulation of cell-cycle progression and centrosome duplication [J]. Oncogene, 2012, doi: 10.1038/onc.2012.195[Epub ahead of print]

[70]Fan L, Pellegrin S, Scott A, et al. The small GTPase Rif is an alternative trigger for the formation of actin stress fibers in epithelial cells [J]. J Cell Sci, 2010, 123(Pt 8): 1247-1252

[71]Fujisawa K, Fujita A, Ishizaki T, et al. Identification of the Rho-binding domain of p160ROCK, a Rho-associated coiled-coil containing protein kinase [J]. J Biol Chem, 1996, 271(38): 23022-23028

[72]Roovers K, Assoian R K. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G (1) phase cyclin-dependent kinases[J].Mol Cell Biol, 2003, 23(12): 4283-4294

[73]Qing H, Gong W, Che Y, et al. PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation [J]. Tumour Biol, 2012, 33(4): 985-994

[74]Shrestha Y, Schafer EJ, Boehm JS, et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling [J]. Oncogene, 2012, 31(29): 3397-3408

[75]Malumbres M, Barbacid M. RAS oncogenes: the first 30 years[J].Nat Rev Cancer,2003,3(6):459-465

[76]Lord CJ, Ashworth A. The DNA damage response and cancer therapy [J]. Nature, 2012, 481(7381): 287-294

[77]Branzei D,Foiani M. Regulation of DNA repair throughout the cell cycle [J]. Nat Rev Mol Cell Biol, 2008, 9(4): 297-308

[78]Croft DR, Crighton D, Samuel MS, et al. p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survival [J]. Cell Res, 2011, 21(4): 666-682

[79]Santamaria D. Ortega S. Cyclins and CDKS in development and cancer: lessons from genetically modified mice [J]. Front Biosci, 2006, 11: 1164-1188

[80]Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective [J]. Oncogene, 2005, 24(17): 2909-2915

[81]Baumann P, West S C.Role of the human RAD51 protein in homologous recombination and double-stranded-break repair [J]. Trends Biochem Sci, 1998, 23(7): 247-251

[82] Shaheen M, Allen C, Nickoloff JA, et al. Synthetic lethality: exploiting the addiction of cancer to DNA repair [J]. Blood, 2011, 117(23): 6074-6082

[83] Jirawatnotai S, Hu Y, Michowski W, et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers[J].Nature,2011,474(7350): 230-234